Postcoital Contraception — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for postcoital contraception. 12 active patents protecting 1 drugs from 1+ originators. First major cliff: 2027. Daily refresh.

1
Approved drugs
12
Active US patents
48/100
Avg vulnerability
—
Annual revenue covered

Originators in Postcoital Contraception

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Fdn Consumer 12 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating postcoital contraception. Each bar = one year. Y-axis scaled to peak year (6 patents).

2
27
6
29
2
33
1
34
1
40

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Jadelle
LEVONORGESTREL
 Fdn Consumer 12 48 — 2027-02-07

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11850182 Jadelle method of use 64 2029-09-14
11850182 Jadelle method of use 64 2029-09-14
11850182 Jadelle method of use 64 2029-09-14
11628088 Jadelle formulation 51 2027-02-07
11628088 Jadelle formulation 51 2027-02-07
10561524 Jadelle method of use 51 2029-09-16
10561524 Jadelle method of use 51 2029-09-16
10561524 Jadelle method of use 51 2029-09-16
11090186 Jadelle method of use 45 2033-10-24
10028858 Jadelle method of use 45 2034-03-22

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
12004992 Jadelle composition of matter 0 2033-10-06
11571328 Jadelle formulation 33 2040-09-07
10028858 Jadelle method of use 45 2034-03-22
11090186 Jadelle method of use 45 2033-10-24
10561524 Jadelle method of use 51 2029-09-16
10561524 Jadelle method of use 51 2029-09-16
10561524 Jadelle method of use 51 2029-09-16
11628088 Jadelle formulation 51 2027-02-07
11628088 Jadelle formulation 51 2027-02-07
11850182 Jadelle method of use 64 2029-09-14

Related